Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Erik Engelson
AddedMar 31, 2024
UpdatedMay 31, 2026
Erik Engelson

Erik Engelson

Board Member, Lucira Health

CrunchbaseLinkedIn

Erik Engelson's Career

Lucira Health
Lucira Health

Emeryville, CA, US

Board Member· Board
Niveus Medical
Niveus Medical

Redwood City, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Erik Engelson's Career

Lucira Health
Lucira Health
Public$147.3M1412013Emeryville, CA, US
Board Member· Board

Leadership at Lucira Health

Sandra GardinerSandra GardinerBoard Member
John WaldeisenJohn WaldeisenFounder
Debkishore MitraDebkishore MitraFounder
David LamondDavid LamondBoard Member

Similar to Lucira Health

LuminosticsLuminosticsSan Jose, CA, USDisease Testingest. 2014LuminosticsSan Jose, CA, US · est. 2014

Luminostics: Innovating DIY disease testing with our smartphone adaptor.

Seed · $2M25
Accessible DiagnosticsAccessible DiagnosticsGreenville, SC, USMedical Testsest. 2014Accessible DiagnosticsGreenville, SC, US · est. 2014

Accessible Diagnostics: Providing at-home, smartphone-based medical tests for healthier families.

Seed · $219k3
Spot HealthSpot HealthCincinnati, OH, USDiagnostic Testsest. 2021Spot HealthCincinnati, OH, US · est. 2021

Spot: At-home lab test services for brands via a white-labeled platform.

Seed · $500k7
Burst DiagnosticsBurst DiagnosticsFort Collins, CO, USDiagnostic Testsest. 2020Burst DiagnosticsFort Collins, CO, US · est. 2020

Burst Diagnostics: Innovating rapid, at-home diagnostic solutions with our automated lab-in-hand platform.

Seed · $2.7M12
Niveus Medical
Niveus Medical
Seed$4.2M302008Redwood City, CA, US
Board Member· Board

Leadership at Niveus Medical

Brian FaheyBrian FaheyFounder & CEO

Similar to Niveus Medical

Niche BiomedicalNiche BiomedicalLos Angeles, CA, USMedical Devicesest. 2016Niche BiomedicalLos Angeles, CA, US · est. 2016

Niche Biomedical: Innovating neuromodulation devices for enhanced human health.

Pre-Seed · $1.4M15
NirvaMedNirvaMedMinneapolis, MN, USMedical Devicesest. 2019NirvaMedMinneapolis, MN, US · est. 2019

NirvaMed: Innovating heart attack treatment with unique, non-invasive solutions for myocardial infarctions.

Series A · $5.1M5
Invent MedicalInvent MedicalCarlsbad, CA, USMedical Devicesest. 2014Invent MedicalCarlsbad, CA, US · est. 2014

Invent Respiratory: Developing advanced respiratory care devices for patient recovery and rehabilitation.

Seed · $258.1k6
NuvetaNuvetaPortola Valley, CA, USMedical Technologyest. 2009NuvetaPortola Valley, CA, US · est. 2009

US-based Nuveta Inc. provides innovative medical technology services.

Pre-Seed · $800k30

Erik Engelson's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Erik Engelson

Daniel WeinsteinDaniel WeinsteinCo-Founder · HAX GrowthMathew RothwayMathew RothwayCo-Founder · Lucia Health GuidelinesLishan AklogLishan AklogBoard Member · Lucid DiagnosticsGina GordonGina GordonCo-Founder · LucitNeeraj SatijaNeeraj SatijaCo-Founder · LucrismaGrace ChenGrace ChenCo-Founder · LucidAct Health